TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network. March 26, 2004
TCL Archive Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds April 26, 2013